LISA KIRK: Open Payments
NPI 1699430637 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 76 payments from 13 companies in 2025. Trend: 2023 $2,339 · 2024 $2,217 · 2025 $1,621
Food & beverage: $1,461Education: $160
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $304 |
| GENZYME CORPORATION | 10 | $274 |
| Janssen Biotech, Inc. | 12 | $265 |
| Galderma Laboratories, L.P. | 12 | $183 |
| ABBVIE INC. | 6 | $170 |
| LEO Pharma Inc. | 9 | $155 |
| Organon LLC | 7 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| UCB, Inc. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
Products named: DUPIXENT, TREMFYA, ILUMYA, NEMLUVIO, SKYRIZI, ADBRY, Bimzelx, COSENTYX.
Industry payments across MS — which companies pay providers there.
